{"id":4006,"date":"2025-04-16T18:04:54","date_gmt":"2025-04-17T01:04:54","guid":{"rendered":"http:\/\/54.162.83.219\/?p=4006"},"modified":"2025-04-16T18:05:52","modified_gmt":"2025-04-17T01:05:52","slug":"celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance","status":"publish","type":"post","link":"https:\/\/guru.today\/?p=4006","title":{"rendered":"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 “Strengthening Global Pharmerging Dominance”"},"content":{"rendered":"\n
\"\"
(Photo : Celltrion)<\/figcaption><\/figure>\n\n\n\n

South Korean pharmaceutical company Celltrion is expanding its influence in Latin America, a major global pharmerging market, by securing consecutive bidding successes.<\/p>\n\n\n\n

According to Celltrion on the 17th, the company has successfully extended the supply period for its breast and gastric cancer treatment ‘Herzuma’ (ingredient: trastuzumab) in Brazil, the largest pharmaceutical market in Latin America. Celltrion\u2019s Brazilian subsidiary has won the federal government\u2019s trastuzumab tender for five consecutive years since Herzuma\u2019s launch in 2020 through last year. Recently, it secured another extension, ensuring supply until March 2026.<\/p>\n\n\n\n

This tender accounts for 97% of Brazil\u2019s trastuzumab market, meaning Celltrion is poised to maintain stable sales in the region this year.<\/p>\n\n\n\n

In Guatemala, ‘Vegzelma’ (ingredient: bevacizumab), a metastatic colorectal and breast cancer treatment set for launch next month, has already secured a successful bid from the Guatemalan Social Security Institute (IGSS), which controls 95% of the market. This allows Vegzelma to dominate the market immediately upon launch. Guatemala often extends supply periods rather than holding new tenders upon expiration, making early success crucial. With Vegzelma\u2019s pre-launch market capture, sustained supply performance is expected. Currently, ‘Truxima’ (ingredient: rituximab), a blood cancer treatment, holds a 70% market share in Guatemala as the most prescribed drug. Celltrion plans to further expand its presence with a stronger oncology portfolio.<\/p>\n\n\n\n

In Costa Rica, Herzuma has secured an additional supply extension in a tender by the Costa Rican Social Security Fund (CCSS), which holds 95% of the market, ensuring supply through the first half of this year. Both Truxima and Herzuma have consistently won bids every year since their launches in 2019 and 2021, respectively, maintaining over 90% market share and leading prescription rates.<\/p>\n\n\n\n

Celltrion has closely analyzed the pharmaceutical market characteristics of each Latin American country, leveraging its product competitiveness and supply stability to dominate tender markets. The company has also focused on building strong networks with key stakeholders, including government bidding agencies and healthcare professionals. Additionally, the trust of local physicians who have used Celltrion\u2019s products for years has solidified its position as a top-pick treatment in the region, positively impacting bid success.<\/p>\n\n\n\n

Celltrion plans to sustain its growth in Latin America by expanding its product lineup and sales countries. Alongside Vegzelma, the company aims to reinforce its portfolio with upcoming launches, including ‘Remsima SC’, the world\u2019s only subcutaneous infliximab formulation, and ‘Yuflyma’ (ingredient: adalimumab), an autoimmune disease treatment, to maximize synergy across its offerings.<\/p>\n\n\n\n

Kang Kyung-doo, Head of Celltrion\u2019s Latin America division, stated, \u201cAs Celltrion\u2019s market dominance grows in Latin America, aggressive marketing efforts by our experienced local teams will further amplify our success. We will continue strengthening our direct sales capabilities to ensure our treatments improve the quality of life for more patients in this steadily growing pharmaceutical market.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"

South Korean pharmaceutical company Celltrion is expanding its influence in Latin America, a major global pharmerging market, by<\/p>\n","protected":false},"author":2,"featured_media":4009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[38,57,35,54],"tags":[],"class_list":["post-4006","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-stories","category-editors-choice","category-feature-focus","category-top-section"],"yoast_head":"\nCelltrion Expands Bidding Success in Key Latin American Markets\u2026 "Strengthening Global Pharmerging Dominance" | GURU TODAY<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 "Strengthening Global Pharmerging Dominance"\" \/>\n<meta property=\"og:description\" content=\"South Korean pharmaceutical company Celltrion is expanding its influence in Latin America, a major global pharmerging market, by\" \/>\n<meta property=\"og:url\" content=\"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/\" \/>\n<meta property=\"og:site_name\" content=\"GURU TODAY\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T01:04:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-17T01:05:52+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/54.162.83.219\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"875\" \/>\n\t<meta property=\"og:image:height\" content=\"505\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Guru Today\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Guru Today\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#article\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/\"},\"author\":{\"name\":\"Guru Today\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#\\\/schema\\\/person\\\/4a34c68d30e200dcc09b1c284abf1e10\"},\"headline\":\"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 “Strengthening Global Pharmerging Dominance”\",\"datePublished\":\"2025-04-17T01:04:54+00:00\",\"dateModified\":\"2025-04-17T01:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/\"},\"wordCount\":470,\"commentCount\":0,\"publisher\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#organization\"},\"image\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/\uc140\ud2b8\ub9ac\uc628-1.jpg\",\"articleSection\":[\"All Stories\",\"Editor-s Choice\",\"Feature Focus\",\"Top section\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/\",\"url\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/\",\"name\":\"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 \\\"Strengthening Global Pharmerging Dominance\\\" | GURU TODAY\",\"isPartOf\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#primaryimage\"},\"image\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/\uc140\ud2b8\ub9ac\uc628-1.jpg\",\"datePublished\":\"2025-04-17T01:04:54+00:00\",\"dateModified\":\"2025-04-17T01:05:52+00:00\",\"breadcrumb\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/\uc140\ud2b8\ub9ac\uc628-1.jpg\",\"contentUrl\":\"https:\\\/\\\/guru.today\\\/wp-content\\\/uploads\\\/\uc140\ud2b8\ub9ac\uc628-1.jpg\",\"width\":875,\"height\":505},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\\\/\\\/54.162.83.219\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 “Strengthening Global Pharmerging Dominance”\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#website\",\"url\":\"http:\\\/\\\/54.162.83.219\\\/\",\"name\":\"GURU TODAY\",\"description\":\"\",\"publisher\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\\\/\\\/54.162.83.219\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#organization\",\"name\":\"GURU TODAY\",\"url\":\"http:\\\/\\\/54.162.83.219\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/54.162.83.219\\\/wp-content\\\/uploads\\\/Logo_white-1.png\",\"contentUrl\":\"http:\\\/\\\/54.162.83.219\\\/wp-content\\\/uploads\\\/Logo_white-1.png\",\"width\":1000,\"height\":167,\"caption\":\"GURU TODAY\"},\"image\":{\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"http:\\\/\\\/54.162.83.219\\\/#\\\/schema\\\/person\\\/4a34c68d30e200dcc09b1c284abf1e10\",\"name\":\"Guru Today\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/087ed7eaf19428dfed2d14fd355333d6e58dbe23fcd3f8e96d2e9290d8bea6d1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/087ed7eaf19428dfed2d14fd355333d6e58dbe23fcd3f8e96d2e9290d8bea6d1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/087ed7eaf19428dfed2d14fd355333d6e58dbe23fcd3f8e96d2e9290d8bea6d1?s=96&d=mm&r=g\",\"caption\":\"Guru Today\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 \"Strengthening Global Pharmerging Dominance\" | GURU TODAY","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/","og_locale":"en_US","og_type":"article","og_title":"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 \"Strengthening Global Pharmerging Dominance\"","og_description":"South Korean pharmaceutical company Celltrion is expanding its influence in Latin America, a major global pharmerging market, by","og_url":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/","og_site_name":"GURU TODAY","article_published_time":"2025-04-17T01:04:54+00:00","article_modified_time":"2025-04-17T01:05:52+00:00","og_image":[{"width":875,"height":505,"url":"http:\/\/54.162.83.219\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg","type":"image\/jpeg"}],"author":"Guru Today","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Guru Today","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#article","isPartOf":{"@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/"},"author":{"name":"Guru Today","@id":"http:\/\/54.162.83.219\/#\/schema\/person\/4a34c68d30e200dcc09b1c284abf1e10"},"headline":"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 “Strengthening Global Pharmerging Dominance”","datePublished":"2025-04-17T01:04:54+00:00","dateModified":"2025-04-17T01:05:52+00:00","mainEntityOfPage":{"@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/"},"wordCount":470,"commentCount":0,"publisher":{"@id":"http:\/\/54.162.83.219\/#organization"},"image":{"@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#primaryimage"},"thumbnailUrl":"https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg","articleSection":["All Stories","Editor-s Choice","Feature Focus","Top section"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#respond"]}]},{"@type":"WebPage","@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/","url":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/","name":"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 \"Strengthening Global Pharmerging Dominance\" | GURU TODAY","isPartOf":{"@id":"http:\/\/54.162.83.219\/#website"},"primaryImageOfPage":{"@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#primaryimage"},"image":{"@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#primaryimage"},"thumbnailUrl":"https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg","datePublished":"2025-04-17T01:04:54+00:00","dateModified":"2025-04-17T01:05:52+00:00","breadcrumb":{"@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#primaryimage","url":"https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg","contentUrl":"https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg","width":875,"height":505},{"@type":"BreadcrumbList","@id":"http:\/\/54.162.83.219\/celltrion-expands-bidding-success-in-key-latin-american-markets-strengthening-global-pharmerging-dominance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/54.162.83.219\/"},{"@type":"ListItem","position":2,"name":"Celltrion Expands Bidding Success in Key Latin American Markets\u2026 “Strengthening Global Pharmerging Dominance”"}]},{"@type":"WebSite","@id":"http:\/\/54.162.83.219\/#website","url":"http:\/\/54.162.83.219\/","name":"GURU TODAY","description":"","publisher":{"@id":"http:\/\/54.162.83.219\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/54.162.83.219\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"http:\/\/54.162.83.219\/#organization","name":"GURU TODAY","url":"http:\/\/54.162.83.219\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/54.162.83.219\/#\/schema\/logo\/image\/","url":"http:\/\/54.162.83.219\/wp-content\/uploads\/Logo_white-1.png","contentUrl":"http:\/\/54.162.83.219\/wp-content\/uploads\/Logo_white-1.png","width":1000,"height":167,"caption":"GURU TODAY"},"image":{"@id":"http:\/\/54.162.83.219\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"http:\/\/54.162.83.219\/#\/schema\/person\/4a34c68d30e200dcc09b1c284abf1e10","name":"Guru Today","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/087ed7eaf19428dfed2d14fd355333d6e58dbe23fcd3f8e96d2e9290d8bea6d1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/087ed7eaf19428dfed2d14fd355333d6e58dbe23fcd3f8e96d2e9290d8bea6d1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/087ed7eaf19428dfed2d14fd355333d6e58dbe23fcd3f8e96d2e9290d8bea6d1?s=96&d=mm&r=g","caption":"Guru Today"}}]}},"rttpg_featured_image_url":{"full":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg",875,505,false],"landscape":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg",875,505,false],"portraits":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg",875,505,false],"thumbnail":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1-150x150.jpg",150,150,true],"medium":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1-300x173.jpg",300,173,true],"large":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg",640,369,false],"1536x1536":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg",875,505,false],"2048x2048":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1.jpg",875,505,false],"morenews-large":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1-825x505.jpg",825,505,true],"morenews-medium":["https:\/\/guru.today\/wp-content\/uploads\/\uc140\ud2b8\ub9ac\uc628-1-590x410.jpg",590,410,true]},"rttpg_author":{"display_name":"Guru Today","author_link":"https:\/\/guru.today\/?author=2"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/guru.today\/?cat=38\" rel=\"category\">All Stories<\/a> <a href=\"https:\/\/guru.today\/?cat=57\" rel=\"category\">Editor-s Choice<\/a> <a href=\"https:\/\/guru.today\/?cat=35\" rel=\"category\">Feature Focus<\/a> <a href=\"https:\/\/guru.today\/?cat=54\" rel=\"category\">Top section<\/a>","rttpg_excerpt":"South Korean pharmaceutical company Celltrion is expanding its influence in Latin America, a major global pharmerging market, by","_links":{"self":[{"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts\/4006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4006"}],"version-history":[{"count":2,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts\/4006\/revisions"}],"predecessor-version":[{"id":4010,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/posts\/4006\/revisions\/4010"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=\/wp\/v2\/media\/4009"}],"wp:attachment":[{"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/guru.today\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}